CRMD FY 2013 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$529M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2,000

Gross Profit

-$199,604-9980.2% margin

Operating Income

-$5M-245769.8% margin

Net Income

-$9M-456654.9% margin

EPS (Diluted)

$-3.30

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$3M

Total Liabilities

$7M

Stockholders' Equity

-$4M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2,000	$0	—
Gross Profit	-$199,604	$0	—
Operating Income	-$5M	-$3M	-61.4%
Net Income	-$9M	-$3M	-166.6%